APA (7th ed.) Citation

Huang, S. (2018). Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice [Gastrointestinal, Hepatic, Pulmonary, and Renal]. The American Society for Pharmacology and Experimental Therapeutics.

Chicago Style (17th ed.) Citation

Huang, S. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice [Gastrointestinal, Hepatic, Pulmonary, and Renal]. The American Society for Pharmacology and Experimental Therapeutics, 2018.

MLA (9th ed.) Citation

Huang, S. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice [Gastrointestinal, Hepatic, Pulmonary, and Renal]. The American Society for Pharmacology and Experimental Therapeutics, 2018.